Cargando…

Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial

IMPORTANCE: Postpartum depression (PPD) is one of the most common medical complications during and after pregnancy, negatively affecting both mother and child. OBJECTIVE: To demonstrate the efficacy and safety of zuranolone, a neuroactive steroid γ-aminobutyric acid receptor–positive allosteric modu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deligiannidis, Kristina M., Meltzer-Brody, Samantha, Gunduz-Bruce, Handan, Doherty, James, Jonas, Jeffrey, Li, Sigui, Sankoh, Abdul J., Silber, Christopher, Campbell, Andrew D., Werneburg, Brian, Kanes, Stephen J., Lasser, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246337/ https://www.ncbi.nlm.nih.gov/pubmed/34190962 http://dx.doi.org/10.1001/jamapsychiatry.2021.1559

Ejemplares similares

A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults
por: Bullock, Amy, et al.
Publicado: (2021)

Rapid improvements in MADRS with zuranolone in major depressive disorder and postpartum depression: results from the LANDSCAPE/NEST clinical development programmes
por: Clayton, A. H., et al.
Publicado: (2023)

Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program
por: Clayton, A., et al.
Publicado: (2022)

Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
por: Meltzer-Brody, Samantha, et al.
Publicado: (2020)

Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)

Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making
por: Gerbasi, Margaret E., et al.
Publicado: (2021)

Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression
por: Gerbasi, Margaret E., et al.
Publicado: (2020)

New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum
por: Meltzer-Brody, Samantha
Publicado: (2011)

Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(A) receptor positive allosteric modulator
por: Althaus, Alison L., et al.
Publicado: (2020)

Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses
por: Lin, Yu-Wei, et al.
Publicado: (2023)

Development of neuroactive steroids for the treatment of postpartum depression
por: Gunduz‐Bruce, Handan, et al.
Publicado: (2021)

Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression
por: Carlini, Sara V, et al.
Publicado: (2023)

Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial
por: Sonoyama, Takuhiro, et al.
Publicado: (2023)

Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants
por: Kaufman, Yardana, et al.
Publicado: (2022)

SAGE-217, A Novel GABA(A) Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies
por: Hoffmann, Ethan, et al.
Publicado: (2019)

Divergent Transcriptomic Effects of Allopregnanolone in Postpartum Depression
por: Rudzinskas, Sarah A., et al.
Publicado: (2023)

App-Based Ecological Momentary Assessment to Enhance Clinical Care for Postpartum Depression: Pilot Acceptability Study
por: Krohn, Holly, et al.
Publicado: (2022)

Diuretics vs. placebo for postpartum blood pressure control in preeclampsia (DIUPRE): a randomized clinical trial
por: Cursino, Telma, et al.
Publicado: (2015)

Cross-continental collaboration for understanding postpartum major depression with psychotic features
por: Kimmel, Mary, et al.
Publicado: (2022)

Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States
por: Eldar-Lissai, Adi, et al.
Publicado: (2020)

PPD ACT: an app-based genetic study of postpartum depression
por: Guintivano, Jerry, et al.
Publicado: (2018)

Transcriptome-wide association study for postpartum depression implicates altered B-cell activation and insulin resistance
por: Guintivano, Jerry, et al.
Publicado: (2022)

Optimizing the treatment of mood disorders in the perinatal period
por: Meltzer-Brody, Samantha, et al.
Publicado: (2015)

Genome-wide gene expression changes in postpartum depression point towards an altered immune landscape
por: Mehta, Divya, et al.
Publicado: (2021)

A Comparison of Bioimpedance Analysis vs. Dual X-ray Absorptiometry for Body Composition Assessment in Postpartum Women and Non-Postpartum Controls
por: Garr Barry, Valene, et al.
Publicado: (2022)

Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression
por: Katz, Eva G., et al.
Publicado: (2020)

Interpersonal therapy versus antidepressant medication for treatment of postpartum depression and anxiety among women with HIV in Zambia: a randomized feasibility trial
por: Spelke, M. Bridget, et al.
Publicado: (2022)

Using Animal Models to Disentangle the Role of Genetic, Epigenetic, and Environmental Influences on Behavioral Outcomes Associated with Maternal Anxiety and Depression
por: Tarantino, Lisa M., et al.
Publicado: (2011)

Stable Configurations of DOXH Interacting with Graphene: Heuristic Algorithm Approach Using NSGA-II and U-NSGA-III
por: Sumetpipat, Kanes, et al.
Publicado: (2022)

The PPD-ACT app in Canada: feasibility and a latent class analysis of participants with postpartum depression recruited to a psychiatric genetics study using a mobile application
por: Collaton, Joanna, et al.
Publicado: (2022)

Towards better understanding of workplace factors contributing to hospitalist burden and burnout prior to COVID-19 pandemic
por: Mazur, Lukasz M, et al.
Publicado: (2023)

“Passing through difficult times”: Perceptions of perinatal depression and treatment needs in Malawi - A qualitative study to inform the development of a culturally sensitive intervention
por: Ng’oma, Mwawi, et al.
Publicado: (2019)

Scaling Up Patient-Centered Psychological Treatments for Perinatal Depression in the Wake of a Global Pandemic
por: Singla, Daisy R., et al.
Publicado: (2022)

Persistent vs Recurrent Cushing's Disease Diagnosed Four Weeks Postpartum
por: Shah, Leena, et al.
Publicado: (2022)

Genetic risk scores for major psychiatric disorders and the risk of postpartum psychiatric disorders
por: Bauer, Anna E., et al.
Publicado: (2019)

Dexametasona intralesional vs placebo en pterigión recidivante
por: Palacios López, Elizabeth
Publicado: (2003)

The Prefrontal Cortex and Suggestion: Hypnosis vs. Placebo Effects
por: Parris, Benjamin A.
Publicado: (2016)

Comparison of Postpartum Opioid Prescriptions Before vs During the COVID-19 Pandemic
por: Steuart, Shelby R., et al.
Publicado: (2023)

Targeting the Arginine Vasopressin V(1b) Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
por: Kanes, Stephen J, et al.
Publicado: (2023)

The longitudinal effects of stress and fear on psychiatric symptoms in mothers during the COVID-19 pandemic
por: Bauer, Anna E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_347551us04ln4cnelrp4nt4upi